What is the recommended dosage for Saccharomyces boulardii?

General: 250-500 mg/day (equivalent to 5-10 billion CFU); Aad Prevention: 500 mg/day (start with antibiotic, continue 7 days after); C Diff Prevention: 500 mg twice daily as adjunct to standard therapy; Travelers Diarrhea: 250-500 mg/day starting 5 days before travel

What are the side effects of Saccharomyces boulardii?

Potential side effects include: Mild gas and bloating, Rare: fungemia in critically ill patients with central venous catheters, Thirst (yeast may increase water requirements), Very rare: potential environmental contamination risk in ICU settings.

What is Saccharomyces boulardii and how does it work for gut health?

Saccharomyces boulardii is a beneficial yeast (not a bacterium) that has been used as a probiotic since the 1950s. Unlike bacterial probiotics, it is naturally resistant to antibiotics, making it particularly useful during antibiotic therapy. It works by producing proteases that neutralize bacterial toxins, strengthening intestinal barrier function, and modulating the immune response. It is one of the most evidence-supported probiotics for diarrheal conditions.

What is the recommended dosage of Saccharomyces boulardii?

The standard clinical dosage is 250-500 mg (equivalent to 5-10 billion CFU) taken 1-2 times daily. The strain S. boulardii CNCM I-745 (marketed as Florastor) is the most extensively studied. For preventing antibiotic-associated diarrhea, it should be started on the first day of antibiotic therapy and continued for 2 weeks after antibiotics are completed.

Are there side effects or interactions with Saccharomyces boulardii?

S. boulardii is generally well-tolerated with a good safety profile. Rarely, it may cause gas or bloating. It should be avoided in patients with central venous catheters due to rare reports of fungemia. Because it is a yeast, it is resistant to antibacterial antibiotics but susceptible to antifungal medications like fluconazole — so it should not be taken concurrently with antifungal drugs.

Saccharomyces boulardii
Saccharomyces boulardii

probiotic_strain

Também conhecido como: S. boulardii, CNCM I-745, Florastor, Saccharomyces cerevisiae var. boulardii

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dsaccharomyces\u002Dboulardii'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

About

Saccharomyces boulardii is a non-pathogenic tropical yeast that supports digestive health through multiple mechanisms. Unlike bacterial probiotics, it is naturally resistant to antibiotics, making it uniquely suited for use alongside antibiotic therapy. Research suggests it may help support the body's defense against C. difficile by secreting a protease that degrades toxins A and B, while also enhancing secretory IgA production and stimulating brush border enzyme activity.

How It Works

Non-pathogenic yeast that secretes a 54-kDa protease degrading C. difficile toxins A and B; enhances secretory IgA production protecting mucosal surfaces; stimulates brush border enzymes (lactase, sucrase, maltase); naturally resistant to all antibacterial antibiotics.

Evidence For Conditions

Condição	Nota	Estudos	Participantes
Antibiotic-Associated Diarrhea (AAD)	A	25	5000	Ver →
Clostridioides difficile Infection (CDI)	B	6	3000	Ver →
Traveler's Diarrhea	B	4	3200	Ver →

Side Effects

Mild gas and bloating
Rare: fungemia in critically ill patients with central venous catheters
Thirst (yeast may increase water requirements)
Very rare: potential environmental contamination risk in ICU settings

Drug & Supplement Interactions

Antifungal medications (may kill S. boulardii, reducing effectiveness)
Monoamine oxidase inhibitors (S. boulardii contains tyramine)
Immunosuppressants (theoretical risk of fungemia in immunocompromised patients)

Informe sempre o seu profissional de saúde sobre todos os suplementos que você toma.Sempre informe seu profissional de saúde sobre todos os suplementos que você toma.

Related Ingredients

Bifidobacterium longum Bifidobacterium bifidum Lactobacillus gasseri Lactobacillus casei Bifidobacterium lactis

Dados Rápidos

Dosagem: General: 250-500 mg/day (equivalent to 5-10 billion CFU); Aad_Prevention: 500 mg/day (start with antibiotic, continue 7 days after); C_Diff_Prevention: 500 mg twice daily as adjunct to standard therapy; Travelers_Diarrhea: 250-500 mg/day starting 5 days before travel
Formas: capsule powder sachet
Fontes Naturais: Originally isolated from lychee and mangosteen fruit skins, Available primarily as commercial supplements
Limite Superior: Well-tolerated up to 1,000 mg/day in clinical trials
Melhor Horário: Can be taken with or without food; space 2 hours from antifungals

Resumo das Evidências

Antibiotic-Associated Diarrhea (AAD) A

Clostridioides difficile Infection (CDI) B

Traveler's Diarrhea B

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.